Volume 27, Number 11—November 2021
Dispatch
Correlation of SARS-CoV-2 Subgenomic RNA with Antigen Detection in Nasal Midturbinate Swab Specimens
Table 2
Variable | Overall, n = 39 | Antigen positive, n = 20 | Antigen negative, n = 19 | p value |
---|---|---|---|---|
Mean age, y (SD) | 8.6 (5.8) | 9.8 (5.6) | 7.4 (5.8) | 0.148 |
Female sex |
16 (41.0) |
8 (40.0) |
8 (42.1) |
0.894 |
Mean days after symptom onset (SD)† | 3.7 (2.2) | 3.0 (1.4) | 4.5 (2.7) | 0.227 |
Repeat NP swab specimen, rRT-PCR positive |
36 (92.3) |
20 (100.0) |
16 (84.2) |
0.106 |
Race | ||||
White | 26 (66.67) | 13 (65.0) | 13 (68.42) | 0.077 |
Black/African American | 6 (15.38) | 3 (15.0) | 3 (15.79) | NA |
Asian | 4 (10.26) | 4 (20.0) | 0 | NA |
Biracial |
3 (7.69) |
0 |
3 (15.79) |
NA |
Hispanic ethnicity | 19 (48.72) | 6 (30.0) | 13 (68.42) | 0.016 |
*Values are no. (%) unless indicated otherwise. NA, not available; NP, nasopharyngeal; rRT-PCR, real-time reverse transcription PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †Day sample was collected. One participant was asymptomatic (did not report symptoms in the past 14 days).
1Current affiliation: Pomona College, Claremont, California, USA.
Page created: August 18, 2021
Page updated: October 19, 2021
Page reviewed: October 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.